HSA
OCEA

HBK Sorce Advisory’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

HBK Sorce Advisory’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,293
Closed -$610 – 645
2025
Q1 		$610 Buy
+11,293
New +$2.7K ﹤0.01% 596

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

HBK Sorce Advisory's OCEA Position: Q2 2025 in Review

HBK Sorce Advisory sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 11,293 shares — an estimated $610 sold.

HBK Sorce Advisory first reported a position in OCEA in Q1 2025 and held it in 1 quarter. The position peaked at $610 in Q1 2025. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • HBK Sorce Advisory reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • HBK Sorce Advisory sold 11,293 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $610.
  • HBK Sorce Advisory first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • HBK Sorce Advisory's Ocean Biomedical, Inc. Common Stock position peaked at $610 in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on HBK Sorce Advisory's 13F filing for Q2 2025, filed 4 Aug 2025.